Tumour site specific group (TSSG) - Haematology  Professional information site

Updates in October 2013: On all relevant pages: 'Tumour site specific group (TSSG)' changed to 'Network site specific group (NSSG)'. BMT: New protocol (under 'RIC conditioning'): Intermediate Cord/Cy/Flu/TBI (B.8.0c); Updated (under 'Patient information'): High Dose Treatment and Stem Cell Rescue (PI.9) - in A4 format; New care plan: Intermediate intensity conditioning for cord transplant (N.93); Updated care plan: Umbilical cord cell infusion allo (N.80 - previously N.70). BMT, Lymphoma and Myeloma: New protocol: Filgrastim (G-CSF). Lymphoma care plan: Updated: Rituximab rapid infusion. Deleted, reinstated, then deleted again: Rituximab infusion rates. Reinstated: Rituximab infusion rate - 500 mg, 600 mg, 700 mg and 800 mg (4 care plans). Myeloid care plan: Archived: Asparaginase. Myeloma: Updated protocols: Pomalidomide and low dose dexamethasone (IMNOVID) - previoulsy named 'Pomalidomide and low dose dexamethasone (POMALYST)'; CyBorDex. Myeloma care plans: Archived: C-VAMP; VAD. OUH Clinical Haematology: Archived (from Haem DTU): Anaphylaxis; Desferal teaching manual; Referral form; Unlicensed medicines; Archived (from Red cell and related disorders):Venofer (N.55); Archived (from Clinical care): Anaphylaxis, Cytotoxic drug policy; Extravasation. NSSG meetings: Added: NSSG Annual Report-2012; Haematology Constitituion-2013; Haematology Work Programme-2013, Agenda, Minutes and Action points for NSSG meeting on September 23. Useful links: Added: 'American Society of Hematology', 'British Society for Haematology' and 'British Society of Blood and Marrow Transplantation' websites.